Verity Asset Management, Inc. Invitae Corp Transaction History

Verity Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	BUY	$17.37 - $26.27 $233,487 - $353,121	13,442 New	13,442 $99,000
Q1 2019 May 13, 2019	SELL	$10.65 - $25.75 $121,516 - $293,807	-11,410 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$9.26 - $16.38 $105,656 - $186,895	11,410 New	11,410 $126,000
Q3 2018 Nov 13, 2018	SELL	$7.54 - $18.31 $101,352 - $246,123	-13,442 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$4.87 - $8.42 $13,110 - $22,666	-2,692 Reduced 16.69%	13,442 $99,000
Q1 2018 May 02, 2018	SELL	$4.69 - $10.05 $42,453 - $90,972	-9,052 Reduced 35.94%	16,134 $76,000
Q4 2017 Feb 07, 2018	BUY	$7.86 - $9.99 $197,961 - $251,608	25,186	25,186 $174,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Verity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Verity Asset Management, Inc. with notifications on news.